Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Carbon-11 UCB-J - Rodin Therapeutics/UCB Biopharma

Next Previous
Drug Profile

Carbon-11 UCB-J - Rodin Therapeutics/UCB Biopharma

Alternative Names: (11)C-UCB-J - Rodin Therapeutics/UCB Biopharma; SV2A PET radiotracer - Rodin Therapeutics/UCB Biopharma

Latest Information Update: 28 Aug 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator UCB Biopharma
  • Developer Rodin Therapeutics
  • Class Fluorobenzenes; Imaging agents; Pyridines; Pyrrolidinones; Radiopharmaceutical diagnostics
  • Mechanism of Action Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Alzheimer's disease

Most Recent Events

  • 28 Aug 2021 No recent reports of development identified for phase-I development in Alzheimer's-disease(Diagnosis) in Netherlands (IV, Injection)
  • 25 Jan 2021 Yale University plans a clinical trial for Cocaine related disorders (Diagnosis) in June 2021 (IV) (NCT04721418)
  • 23 Mar 2020 Stanford University plans a phase I trial for Major depressive disorder (Diagnosis, In volunteers) in USA (IV) in December 2020 (NCT04311619)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top